Its not always necessary to pinch your skin for this type of shot, especially if you have a certain body type or use a shorter needle
External resources PMC: The physiology of weight loss plateaus during obesity pharmacotherapy , a comprehensive analysis of metabolic adaptation mechanisms during GLP-1 receptor agonist therapy, including appetite feedback coefficients and energy expenditure changes
Several long-acting GLP-1 RAs have demonstrated CV protection in a dedicated CV outcome trial (CVOT) [7,8,9,10, 38] while the SURPASS-CVOT study (NCT04255433) for tirzepatide is ongoing and will provide further insights into whether these effects on blood pressure lowering, improvements in metabolic parameters and elevation in heart rate would combine to produce any meaningful impact on hard CV outcomes
PMC (2019) Subcutaneous drug delivery: pharmacologic considerations and techniques American College of Cardiology (2025) REDEFINE 1 and REDEFINE 2 journal scan summary The Lancet (2023) Efficacy and safety of CagriSema in type 2 diabetes: phase 2 trial (Frias et al.) PMC (2024) Efficacy and safety of cagrilintide and CagriSema: systematic review and metaanalysis Pure Lab Peptides Cagrilintide (5 mg) product page (quality and batch documentation) Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides